EMRUSOLMIN

Dead / Abandoned — Abandoned — express abandonment (as of 30 Jun 2022)

What this means for you

This application is over — abandoned 29 Jun 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
97423939
Mark type
Stylized text
Filed
23 May 2022
Abandoned
29 Jun 2022
Attorney of record
Timothy J. Maier

Goods and services

  • Class 005 — Pharmaceuticals: Medicines for human purposes; Medicines for veterinary purposes; Pharmaceuticals and natural remedies; Medicines for the treatment of Alzheimer's disease; Medicines for the treatment of neurodegenerative diseases; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Chemico-pharmaceutical preparations; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations and materials; Diagnostic biomarker reagents for medical purposes; Diagnostic reagents for medical use; Dragees; Injectable pharmaceuticals; Medicinal preparations and substances; Antiparkinson agents; Pharmaceutical drugs; Pharmaceuticals; Pharmaceutical preparations for human use; Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for the treatment of Alzeimer's disease; Pharmaceutical preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for the treatment of cerebral disease; Pharmaceutical preparations for the treatment of central nervous system diseases
  • Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consultancy relating to pharmaceutical research and development; Biological research, clinical research and medical research; Medical research laboratory services; Testing of pharmaceuticals; Analysis of human serum for medical research; Analysis of human tissues for medical research; Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Research and development of vaccines and medicines; Providing scientific information in the field of medical disorders and their treatment; Research in the field of pharmacogenetics; Research on the subject of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Clinical research; Laboratory research services relating to pharmaceuticals; Medical research; Medical and pharmacological research services; Pharmaceutical drug development services; Pharmaceutical research services; Pharmaceutical research and development; Inspection of pharmaceuticals; Scientific research in the field of pharmacy; Scientific research and development
  • Class 044 — Medical, beauty and agricultural services: Medication counseling; Providing information to patients in the field of administering medications; Provision of information relating to pharmaceutical products; Provision of information relating to the treatment of degenerative diseases; Provision of information relating to medical services; Provision of pharmaceutical information; Advisory services relating to the treatment of degenerative diseases; Consultancy and information services relating to pharmaceutical products; Consultancy and information services provided via the Internet relating to pharmaceutical products; Consultancy and information services relating to medical products; Advisory services relating to medicines; Medical services; Medical services for treating Alzheimer's disease; Pharmaceutical services; Preparation and dispensing of medications

Owner

Prosecution history

  • 30 Jun 2022 — ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
  • 30 Jun 2022 — ABANDONMENT - EXPRESS MAILED
  • 29 Jun 2022 — TEAS EXPRESS ABANDONMENT RECEIVED
  • 27 Jun 2022 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
  • 27 Jun 2022 — ASSIGNED TO LIE
  • 14 Jun 2022 — TEAS VOLUNTARY AMENDMENT RECEIVED
  • 27 May 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 27 May 2022 — NEW APPLICATION ENTERED

View this trademark record on Marksy